Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-026771
Filing Date
2019-11-06
Accepted
2019-11-06 16:30:33
Documents
1
Period of Report
2019-11-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 18564
  Complete submission text file 0000899243-19-026771.txt   21568
Mailing Address 675 AVENUE OF THE AMERICAS, 6TH FLOOR NEW YORK NY 10010
Business Address
LAINOVIC SACHA (Reporting) CIK: 0001053891 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39112 | Film No.: 191196761

Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Issuer) CIK: 0001720725 (see all company filings)

EIN.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 126 EAST 56TH STREET, 20TH FLOOR NEW YORK NY 10022
Business Address 126 EAST 56TH STREET, 20TH FLOOR NEW YORK NY 10022 212-616-2555
InvOpps IV US, L.P. (Reporting) CIK: 0001745076 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39112 | Film No.: 191196760

Mailing Address 126 EAST 56TH STREET, 20THFLOOR NEW YORK NY 10022
Business Address 126 EAST 56TH STREET, 20THFLOOR NEW YORK NY 10022 212-616-2555
InvOpps GP IV, L.L.C. (Reporting) CIK: 0001792570 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39112 | Film No.: 191196758

Mailing Address 126 EAST 56TH STREET, 20THFLOOR NEW YORK NY 10022
Business Address 126 EAST 56TH STREET, 20THFLOOR NEW YORK NY 10022 212-616-2555
InvOpps IV, L.P. (Reporting) CIK: 0001792575 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39112 | Film No.: 191196759